Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin

Trousil, J., Pavliš, O., Kubíčková, P., Škorič, M., Marešová, V., Pavlova, E., Knudsen, K. D., Dai, Y.-S., Zimmerman, M., Dartois, V., Fang, J.-Y., Hrubý, M. Antitubercular nanocarrier monotherapy: study of in vivo efficacy and pharmacokinetics for rifampicin. Journal of Controlled Release. 2020, 321(10 May), 312-323. ISSN 0168-3659. E-ISSN 1873-4995. Available: doi: 10.1016/j.jconrel.2020.02.026.